Antag Therapeutics appoints Dr. Christine T. Fischette to its Board of Directors
Copenhagen, Denmark, July 15 , 2021 – Antag Therapeutics ApS, a privately-held biotechnology company focused on...
Search for Articles
Jul 15, 2021
Jul 12, 2021
Renovacor Announces the Appointment of Jiwen Zhang, Ph.D., as Senior Vice President, Regulatory Affairs and Quality Assurance
PHILADELPHIA, July 12, 2021 (GLOBE NEWSWIRE) — Renovacor, Inc. (“Renovacor”), an early-stage biotechnology company developing...
Jun 29, 2021
Renovacor Announces the Appointments of Joan Lau, Ph.D., and Gregory F. Covino to its Board of Directors
PHILADELPHIA, June 29, 2021 (GLOBE NEWSWIRE) -- Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing...
Jun 23, 2021
RapidPulse Launches With $15 Million Series A Financing for Ischemic Stroke Therapy
MIAMI, June 23, 2021 (GLOBE NEWSWIRE) -- RapidPulse, Inc., a privately-held medical device company developing...
Jun 2, 2021
Renovacor Announces the Appointment of Marc Semigran, M.D., as Chief Medical Officer
PHILADELPHIA and BOSTON, June 02, 2021 (GLOBE NEWSWIRE) -- Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology...
May 20, 2021
HAYA Therapeutics Completes CHF 18 Million Seed Financing To Advance Anti-fibrotic Therapies Targeting Long Non-coding RNAs
Lausanne, Switzerland, 20 May 2021 -- HAYA Therapeutics, SA, a company developing precision medicines that...